Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Jeffrey Kirshner MD, FACP, FASCO
Jeffrey J. Kirshner MD, FACP, FASCO Advisory Board
Guru Sonpavde MD
Guru P. Sonpavde MD Advisory Board
Annette Hasenburg Prof., Dr, med
Annette Hasenburg Prof., Dr, med Advisory Board
See All Experts
Published in Oncology

Journal Scan / Research · March 25, 2023

Outcomes of Patients With Relapsed MCL Treated With Venetoclax

Blood Advances

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Charles Gaulin MBBS

Blood Advances
A Multicenter Analysis of the Outcomes with Venetoclax in Patients with Relapsed Mantle Cell Lymphoma
Blood Adv 2023 Feb 21;[EPub Ahead of Print], Y Sawalha, S Goyal, JM Switchenko, JT Romancik, M Kamdar, IB Greenwell, BT Hess, KM Isaac, CA Portell, AV Mejia Garcia, SR Goldsmith, NS Grover, PA Riedell, R Karmali, M Burkart, M Buege, OS Akhtar, P Torka, A Kumar, BT Hill, BS Kahl, JB Cohen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated